Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
US8697360B2 · kind B2 · utility
0Cited by
16References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 26, 2008 |
| Grant date | Apr 15, 2014 |
| Priority date | — |
| Expiry date | Feb 15, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
It has been discovered that certain polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention describes diagnostic applications for determining a susceptibility to cancer using such markers, as well as kits for use in such applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.